DSGN
Price
$3.57
Change
-$0.25 (-6.54%)
Updated
Jun 27 closing price
Capitalization
202.66M
43 days until earnings call
NVCT
Price
$7.55
Change
-$0.16 (-2.08%)
Updated
Jun 27 closing price
Capitalization
157.75M
38 days until earnings call
Interact to see
Advertisement

DSGN vs NVCT

Header iconDSGN vs NVCT Comparison
Open Charts DSGN vs NVCTBanner chart's image
Design Therapeutics
Price$3.57
Change-$0.25 (-6.54%)
Volume$170.35K
Capitalization202.66M
Nuvectis Pharma
Price$7.55
Change-$0.16 (-2.08%)
Volume$1.87M
Capitalization157.75M
DSGN vs NVCT Comparison Chart in %
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. NVCT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and NVCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (DSGN: $3.57 vs. NVCT: $7.55)
Brand notoriety: DSGN and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 167% vs. NVCT: 1091%
Market capitalization -- DSGN: $202.66M vs. NVCT: $157.75M
DSGN [@Biotechnology] is valued at $202.66M. NVCT’s [@Biotechnology] market capitalization is $157.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCT is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 3 TA indicator(s) are bullish while NVCT’s TA Score has 3 bullish TA indicator(s).

  • DSGN’s TA Score: 3 bullish, 5 bearish.
  • NVCT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than NVCT.

Price Growth

DSGN (@Biotechnology) experienced а -4.55% price change this week, while NVCT (@Biotechnology) price change was -7.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

DSGN is expected to report earnings on Aug 11, 2025.

NVCT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($203M) has a higher market cap than NVCT($158M). NVCT YTD gains are higher at: 39.556 vs. DSGN (-42.139). NVCT has higher annual earnings (EBITDA): -21.02M vs. DSGN (-67.79M). DSGN has more cash in the bank: 230M vs. NVCT (29.9M). DSGN (0) and NVCT (0) have equivalent revenues.
DSGNNVCTDSGN / NVCT
Capitalization203M158M128%
EBITDA-67.79M-21.02M323%
Gain YTD-42.13939.556-107%
P/E RatioN/AN/A-
Revenue00-
Total Cash230M29.9M769%
Total Debt2.14MN/A-
TECHNICAL ANALYSIS
Technical Analysis
DSGNNVCT
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESMC0.350.04
+12.00%
Escalon Medical Corp.
SHLAF373.058.05
+2.21%
Schindler Holding AG
VOPKF49.11N/A
N/A
Koninklijke Vopak NV
RMRDF0.27-0.01
-3.85%
Radisson Mining Resources Inc.
RNWEY0.20-0.02
-7.11%
REC SILICON ASA

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with TCRT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-6.54%
TCRT - DSGN
56%
Loosely correlated
+2.19%
VRDN - DSGN
48%
Loosely correlated
-1.37%
AURA - DSGN
46%
Loosely correlated
-0.16%
IDYA - DSGN
46%
Loosely correlated
-4.13%
KRYS - DSGN
46%
Loosely correlated
-2.60%
More

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and PDSB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-2.08%
PDSB - NVCT
31%
Poorly correlated
-2.76%
CSCI - NVCT
29%
Poorly correlated
-0.89%
CLDI - NVCT
28%
Poorly correlated
-2.31%
FTRE - NVCT
28%
Poorly correlated
-3.95%
DSGN - NVCT
27%
Poorly correlated
-6.54%
More